Showing results (131-140 of 146) with videos related to

Sort By:
Pageof 15
Cancer|October 15, 1990
Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high-dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (study COSS-86)K Winkler, S Bielack, G Delling, et al.
Klinische Padiatrie|May 1, 1988
[The German Society of Pediatric Oncology Cooperative Ewing Sarcoma Studies CESS 81/86: report after 6 1/2 years]H Jürgens, V Bier, J Dunst, et al.
Klinische Padiatrie|July 1, 1994
[The EWS gene rearrangement in Ewing tumors: key to the disease]H Kovar, A Zoubek, C Pfleiderer, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1989
The role of ifosfamide and cyclophosphamide in the multi-modality treatment after surgery for cure for small-cell bronchial carcinomas (SCLC)K Karrer, H Denck, H Karnicka-Mlodkowska, et al.
International Journal of Cancer|April 21, 1995
High nm23-H1/NDPK-A expression in Ewing tumors: paradoxical immunohistochemical reactivity and lack of prognostic significanceD N Aryee, T Ströbel, K Kos, et al.
Onkologie|April 1, 1989
[Results of treatment in primary disseminated osteosarcoma. Analysis of the follow-up of patients in the cooperative osteosarcoma studies COSS-80 and COSS-82]K Winkler, S Torggler, G Beron, et al.
Klinische Padiatrie|May 1, 1988
[Results of treatment of primary metastatic Ewing sarcoma. A retrospective analysis of 48 patients]R Wessalowski, H Jürgens, H Bodenstein, et al.
International Journal of Clinical Pharmacology Research|January 1, 1990
The importance of surgery as the first step in multimodality treatment of small cell bronchial carcinoma. The ISC Lung Cancer Study GroupK Karrer, H Denck, H Karnicka-Mlodkowska, et al.
British Journal of Cancer|November 1, 1994
Variability of EWS chimaeric transcripts in Ewing tumours: a comparison of clinical and molecular dataA Zoubek, C Pfleiderer, M Salzer-Kuntschik, et al.
International Journal of Clinical Pharmacology Research|January 1, 1988
Surgery for cure followed by combined modality treatment for small cell bronchial carcinoma. ISC Lung Cancer Study GroupK Karrer, H Denck, H Karnicka-Mlodkowska, et al.
Pageof 15